SCHEMBL13487808

SCHEMBL13487808

Cc1ccc2c(-c3cnccn3)c3ccccc3c(-c3ccc4c(c3)C(C)(C)c3ccccc3-4)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.36
FEN1 P39748 2/20 0.36
PDK2 Q15119 7/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2A6 P11509 1/20 0.32
PIM1 P11309 2/20 0.32
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
RECQL P46063 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HRH1 P35367 1/20 0.30
HTR6 P50406 1/20 0.30
EDNRB P24530 1/20 0.30
EDNRA P25101 1/20 0.30
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487448 0.95 ALOX5AP (0.34) ALOX5APFEN1PDK2CYP3A4CYP2A6
SCHEMBL13488127 0.92 ALOX5AP (0.38) ALOX5APFEN1PDK2PIM1SLC6A2
SCHEMBL13487897 0.89 PDK2 (0.38) ALOX5APFEN1PDK2PIM1SLC6A2
SCHEMBL13487754 0.89 ALOX5AP (0.36) ALOX5APFEN1PDK2PIM1SLC6A2
SCHEMBL13487859 0.89 PDK2 (0.42) PDK2KDM4EMEN1ALDH1A1MAPT
SCHEMBL13487838 0.87 PDK2 (0.44) PDK2CYP3A4CYP2A6KDM4EMEN1
SCHEMBL1103622 0.87 PDK2 (0.36) PDK2KDM4EMEN1ALDH1A1LMNA
SCHEMBL13488053 0.87 CYP11B2 (0.36) ALOX5APFEN1PDK2CYP3A4PIM1
SCHEMBL13487982 0.87 ALOX5AP (0.36) ALOX5APFEN1PDK2PIM1KDM4E
SCHEMBL13487042 0.86 CYP3A4 (0.35) ALOX5APFEN1PDK2CYP3A4CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 ALOX5AP 230/4885FEN1 1389/4885PDK2 1456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.